Atlas Trials

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Clinical trial NCT00561366 · WITHDRAWN

Trial details

NCT number
NCT00561366
Sponsor
CytRx
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.